Overview

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.
Phase:
N/A
Details
Lead Sponsor:
University of Giessen
Collaborator:
Indonesian Directorate General of Higher Education
Treatments:
Ethambutol
Isoniazid
Pyrazinamide
Rifampin